Related Experiment Video
Updated: Nov 17, 2025

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope
Manthan Kathrotiya1, Vivek S Radhakrishnan1, Saurabh J Bhave1
1Clinical Haematology Oncology and HCT Tata Medical Center Kolkata India.
This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV-negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.
This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV-negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.

